Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Leirisalo-Repo

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Rheumatology|March 25, 1999
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokineticsI F Anderson, T Helve, P Hannonen, et al.
Annals of the Rheumatic Diseases|January 17, 2009
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)J Sieper, D van der Heijde, R Landewé, et al.
Nature Communications|June 22, 2017
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritisP Savola, T Kelkka, H L Rajala, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Annals of the Rheumatic Diseases|May 14, 2004
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritisJ R Kirwan, R Hällgren, H Mielants, et al.
Lancet (London, England)|May 20, 1999
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial groupT Möttönen, P Hannonen, M Leirisalo-Repo, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiographyX Baraliakos, F Heldmann, J Callhoff, et al.
Annals of the Rheumatic Diseases|August 30, 2005
ASAS/EULAR recommendations for the management of ankylosing spondylitisJ Zochling, D van der Heijde, R Burgos-Vargas, et al.
Annals of the Rheumatic Diseases|March 20, 2009
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisalM Rudwaleit, R Landewé, D van der Heijde, et al.
Rheumatology International|August 6, 2021
Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritisJ Hiltunen, P Parmanne, T Sokka, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Rheumatology|March 25, 1999
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokineticsI F Anderson, T Helve, P Hannonen, et al.
Annals of the Rheumatic Diseases|January 17, 2009
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)J Sieper, D van der Heijde, R Landewé, et al.
Nature Communications|June 22, 2017
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritisP Savola, T Kelkka, H L Rajala, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Annals of the Rheumatic Diseases|May 14, 2004
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritisJ R Kirwan, R Hällgren, H Mielants, et al.
Lancet (London, England)|May 20, 1999
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial groupT Möttönen, P Hannonen, M Leirisalo-Repo, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiographyX Baraliakos, F Heldmann, J Callhoff, et al.
Annals of the Rheumatic Diseases|August 30, 2005
ASAS/EULAR recommendations for the management of ankylosing spondylitisJ Zochling, D van der Heijde, R Burgos-Vargas, et al.
Annals of the Rheumatic Diseases|March 20, 2009
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisalM Rudwaleit, R Landewé, D van der Heijde, et al.
Rheumatology International|August 6, 2021
Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritisJ Hiltunen, P Parmanne, T Sokka, et al.
Pageof 26